ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
- Type
- Retraction
- Notice date
- 4/4/2025 0:00
- Journal
- Cancer Medicine
- Publisher
- Wiley
- Notice DOI
- 10.1002/cam4.70849
- Original paper DOI
- 10.1002/cam4.1634
Reasons
- Duplication of/in Image
- Investigation by Journal/Publisher
- Investigation by Third Party
- Objections by Author(s)
- Unreliable Results and/or Conclusions